Neomycin And Polymyxin B Sulfates And Hydrocortisone

   
Google
 
Web NewDrugInformation.com

Neomycin And Polymyxin B Sulfates And Hydrocortisone


Drug - Neomycin And Polymyxin B Sulfates And Hydrocortisone
The trade name of the product as shown on the labeling.

Dosage - SOLUTION/DROPS; OTIC
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Hydrocortisone; Neomycin Sulfate; Polymyxin B Sulfate
Multiple ingredients are in alphabetical order.

Strength - 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
The potency of the active ingredient(s), Hydrocortisone; Neomycin Sulfate; Polymyxin B Sulfate. May repeat for multiple part products.

Applicant - PHARMAFORCE
The firm name holding legal responsibility for Neomycin And Polymyxin B Sulfates And Hydrocortisone. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 065216
The FDA assigned number to Neomycin And Polymyxin B Sulfates And Hydrocortisone. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Neomycin And Polymyxin B Sulfates And Hydrocortisone. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AT
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 31, 2005
The date Neomycin And Polymyxin B Sulfates And Hydrocortisone was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Neomycin And Polymyxin B Sulfates And Hydrocortisone. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Neomycin And Polymyxin B Sulfates And Hydrocortisone is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pharmaforce Inc
The full name of the firm holding legal responsibility for the new application of Neomycin And Polymyxin B Sulfates And Hydrocortisone.

Neomycin And Polymyxin B Sulfates And Hydrocortisone